Switzerland· 53640060
Vincristine Pfizer, Injektionslösung
A vincristine product containing vincristini sulfas, registered in Switzerland by Pfizer AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Vincristine is registered in 16 of 19 countries.
Countries holding a registration under ATC L01CA02 (vincristine), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 9 of them publish a price we can compare per daily dose
Vincristine · ATC L01CA02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- vincristini sulfas
- Manufacturer
- Pfizer AG
- Country
- Switzerland (CH)
- ATC code
- L01CA02
- ATC class
- Vincristine
- Defined daily dose
- 0.36 mg, P
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin76805364006095 Durchstf 2 mlCHF 126.3
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
583 interactions on record for vincristine.
Graded by severity as the source publishes them — 63 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Vincristine · interactions on record
583 records
- 63 severe
- 282 moderate
- 25 minor
- 213 info
Most severe, free to view
- LonafarnibA16AX20severe
- ConivaptanC03XA02severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Vincristine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVINCRISTINE TEVATeva Pharmaceuticals CR, s.r.o., Praha
- BelgiumVincrisin 1 mg/mlTeva
- SwedenOncovin 1 mg/ml Injektionsvätska, lösningSTADA Nordic ApS
- FinlandVincrinOrion Corporation Orion Pharma
- NorwayVincristine PfizerPfizer AS
- PolandVincristine TevaTeva Pharmaceuticals Polska Sp. z o.o.
- SpainVINCRISTINA PFIZER 1 mg/ml SOLUCION INYECTABLE EFGPfizer S.L.
- United KingdomOncovin 1mg/1ml solution for injection vialsEli Lilly and Company Ltd
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Oncovin, Vincristin Pfizer
- Belgium · Vincrisin
- Czechia · Vincristine Teva
- Germany · Cellcristin, Vincristinsulfat Teva
- Denmark · Oncovin
- Spain · Vincristina Pfizer
- Finland · Oncovin
- France · Oncovin, Vincristine Hospira
- United Kingdom (Northern Ireland) · Vincristine Sulfate Hospira Uk, Vincristine Sulfate Teva Uk
- Ireland · Vincristine Sulfate Pfizer Healthcare Ireland
- Italy · Vincristina, Vincristina Pfizer Italia
- Lithuania · Vincristine Teva
- Luxembourg · Vincrisin
- Latvia · Vincristine Teva
- Netherlands · Vincristinesulfaat Teva
- Norway · Vincristine Pfizer
- Poland · Vincristine Teva
- Portugal · Vincristina Teva
- Romania · Sindovin, Vincristină Teva
- Sweden · Oncovin, Vincristine Pfizer
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9869dda0-3b0c-48f3-995a-ef9303d83fb9 GET /v1/drugs/9869dda0-3b0c-48f3-995a-ef9303d83fb9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "vincristini sulfas 2 mg",
"valid_from": "1997-03-15",
"limitations": "[{\"description\":\"Vergütet wird<br>\\n-\\tdie Behandlung akuter Leukämie;<br>\\n<br>\\n-\\tdie Kombinationstherapie bei M. Hodgkin, Non-Hodgkin-Lymphom, inklusive Sonderformen, Rhabdomyosarkom, Neuroblastom, Wilms-Tumor, osteogenem Sarkom, Ewing-Sarkom, malignem Melanom, kleinzelligem Lungenkarzinom, gynäkologischen Tumoren des Kindesalters;<br>\\n<br>\\n-\\tdie Behandlung idiopathischer thrombozytopenischer Purpura (Morbus Werlhof) bei Patienten, die auf eine Splenektomie und Kurzzeitbehandlung mit Corticosteroiden nicht angesprochen haben.<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2024-02-01\"}]",
"galenic_form": "Inj Lös 2 mg/2ml",
"therapeutic_area": null,
"sl_inclusion_date": "1997-03-15",
"self_retention_pct": 10
}See everything about vincristine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.